Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

MARIE

Reference number
Coordinator Oxlantic Medical AB
Funding from Vinnova SEK 1 879 300
Project duration April 2024 - December 2025
Status Completed
Venture Swelife - Samverkansprojekt för bättre hälsa
Call Swelife - Collaborative projects for better health autumn 2023

Important results from the project

Yes, and the project became even larger and more important than planned because Karolinska´s participation resulted in a PhD position and doubled the number of studies. The project also resulted in clinical data necessary for the CE marking of MARIE.

Expected long term effects

A product that will meet the healthcare´s needs and increase patient safety through continuous respiratory monitoring in new clinical settings. MARIE will likely become standard in many healthcare settings around the world. Thanks to the project, Swedish research in respiratory monitoring and capnography is strengthened. More studies are planned to be carried out in 2026. The project has also contributed to a collaboration between Uppsala and Karolinska.

Approach and implementation

The planned activities were right and well balanced and the team’s competence created positive synergy effects. The collaboration worked excellently and the great interest from the healthcare sector was unexpectedly positive. Karolinska´s unplanned participation contributed to the project being particularly successful and at the same time opened up a collaboration between Uppsala Universitet, Region Uppsala, Karolinska Institutet and Regionen Stockholm regarding research on MARIE.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 6 February 2026

Reference number 2023-04188